Fundraising Fox

Abingworth Bioventures

Venture capital

London

Fox Verdict
Sign up to see your fit

Fund manager profile

Abingworth Bioventures is a venture fund manager based in London. SEC filings show 2 venture funds on record, most recently Abingworth Bioventures 8 LP filed May 2020.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
London
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×3

HQs:United States×2

Investments · 3 tracked

founders shown can be your intro path
Jaspertherapeuticsjaspertherapeutics.cominNASDAQ: JSPRSEC filingmedium confidence

BiotechRedwood City, US

Herb Cross(Executive Officer)Jeet Mahal(Executive Officer, Director)Patrick Crutcher(Director)Thomas Wiggans(Director)Judith Shizuru(Director)Svetlana Lucas(Director)

Board seatKurt von Emster· per SEC Form D · $132M raise · filed Aug 2026

CRISPR Therapeutics AGSEC filingmedium confidence

BiotechBasel

Kurt von Emster(Director)Sven Ante Lundberg(Executive Officer)Thomas Woiwode(Director)Ali Behbahani(Director)Rodger Novak(Executive Officer, Director)Pablo Cagnoni(Director)

Board seatKurt von Emster· per SEC Form D · $35M raise · filed Nov 2016

Iambic Therapeutics, Inc.SEC filingmedium confidence

BiotechSan Diego, US

Jishnu Bhattacharjee(Director)William Rastetter(Director)Fred Manby(Executive Officer, Director)Shalini Sharp(Director)Neil Josephson(Executive Officer)Michael Secora(Executive Officer)

Board seatKurt von Emster· per SEC Form D · $50M raise · filed Apr 2026

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

Where is Abingworth Bioventures located?
Abingworth Bioventures is headquartered in London.

Featured in lists